Proteoglycans act as cellular hepatitis delta virus attachment receptors.

The hepatitis delta virus (HDV) is a small, defective RNA virus that requires the presence of the hepatitis B virus (HBV) for its life cycle. Worldwide more than 15 million people are co-infected with HBV and HDV. Although much effort has been made, the early steps of the HBV/HDV entry process, incl...

Full description

Bibliographic Details
Main Authors: Oscar Lamas Longarela, Tobias T Schmidt, Katrin Schöneweis, Raffaella Romeo, Heiner Wedemeyer, Stephan Urban, Andreas Schulze
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3591349?pdf=render
_version_ 1818136064883163136
author Oscar Lamas Longarela
Tobias T Schmidt
Katrin Schöneweis
Raffaella Romeo
Heiner Wedemeyer
Stephan Urban
Andreas Schulze
author_facet Oscar Lamas Longarela
Tobias T Schmidt
Katrin Schöneweis
Raffaella Romeo
Heiner Wedemeyer
Stephan Urban
Andreas Schulze
author_sort Oscar Lamas Longarela
collection DOAJ
description The hepatitis delta virus (HDV) is a small, defective RNA virus that requires the presence of the hepatitis B virus (HBV) for its life cycle. Worldwide more than 15 million people are co-infected with HBV and HDV. Although much effort has been made, the early steps of the HBV/HDV entry process, including hepatocyte attachment and receptor interaction are still not fully understood. Numerous possible cellular HBV/HDV binding partners have been described over the last years; however, so far only heparan sulfate proteoglycans have been functionally confirmed as cell-associated HBV attachment factors. Recently, it has been suggested that ionotrophic purinergic receptors (P2XR) participate as receptors in HBV/HDV entry. Using the HBV/HDV susceptible HepaRG cell line and primary human hepatocytes (PHH), we here demonstrate that HDV entry into hepatocytes depends on the interaction with the glycosaminoglycan (GAG) side chains of cellular heparan sulfate proteoglycans. We furthermore provide evidence that P2XR are not involved in HBV/HDV entry and that effects observed with inhibitors for these receptors are a consequence of their negative charge. HDV infection was abrogated by soluble GAGs and other highly sulfated compounds. Enzymatic removal of defined carbohydrate structures from the cell surface using heparinase III or the obstruction of GAG synthesis by sodium chlorate inhibited HDV infection of HepaRG cells. Highly sulfated P2XR antagonists blocked HBV/HDV infection of HepaRG cells and PHH. In contrast, no effect on HBV/HDV infection was found when uncharged P2XR antagonists or agonists were applied. In summary, HDV infection, comparable to HBV infection, requires binding to the carbohydrate side chains of hepatocyte-associated heparan sulfate proteoglycans as attachment receptors, while P2XR are not actively involved.
first_indexed 2024-12-11T09:34:28Z
format Article
id doaj.art-c13eeb7bff2945f9b27524f3adadb6fc
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T09:34:28Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c13eeb7bff2945f9b27524f3adadb6fc2022-12-22T01:12:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e5834010.1371/journal.pone.0058340Proteoglycans act as cellular hepatitis delta virus attachment receptors.Oscar Lamas LongarelaTobias T SchmidtKatrin SchöneweisRaffaella RomeoHeiner WedemeyerStephan UrbanAndreas SchulzeThe hepatitis delta virus (HDV) is a small, defective RNA virus that requires the presence of the hepatitis B virus (HBV) for its life cycle. Worldwide more than 15 million people are co-infected with HBV and HDV. Although much effort has been made, the early steps of the HBV/HDV entry process, including hepatocyte attachment and receptor interaction are still not fully understood. Numerous possible cellular HBV/HDV binding partners have been described over the last years; however, so far only heparan sulfate proteoglycans have been functionally confirmed as cell-associated HBV attachment factors. Recently, it has been suggested that ionotrophic purinergic receptors (P2XR) participate as receptors in HBV/HDV entry. Using the HBV/HDV susceptible HepaRG cell line and primary human hepatocytes (PHH), we here demonstrate that HDV entry into hepatocytes depends on the interaction with the glycosaminoglycan (GAG) side chains of cellular heparan sulfate proteoglycans. We furthermore provide evidence that P2XR are not involved in HBV/HDV entry and that effects observed with inhibitors for these receptors are a consequence of their negative charge. HDV infection was abrogated by soluble GAGs and other highly sulfated compounds. Enzymatic removal of defined carbohydrate structures from the cell surface using heparinase III or the obstruction of GAG synthesis by sodium chlorate inhibited HDV infection of HepaRG cells. Highly sulfated P2XR antagonists blocked HBV/HDV infection of HepaRG cells and PHH. In contrast, no effect on HBV/HDV infection was found when uncharged P2XR antagonists or agonists were applied. In summary, HDV infection, comparable to HBV infection, requires binding to the carbohydrate side chains of hepatocyte-associated heparan sulfate proteoglycans as attachment receptors, while P2XR are not actively involved.http://europepmc.org/articles/PMC3591349?pdf=render
spellingShingle Oscar Lamas Longarela
Tobias T Schmidt
Katrin Schöneweis
Raffaella Romeo
Heiner Wedemeyer
Stephan Urban
Andreas Schulze
Proteoglycans act as cellular hepatitis delta virus attachment receptors.
PLoS ONE
title Proteoglycans act as cellular hepatitis delta virus attachment receptors.
title_full Proteoglycans act as cellular hepatitis delta virus attachment receptors.
title_fullStr Proteoglycans act as cellular hepatitis delta virus attachment receptors.
title_full_unstemmed Proteoglycans act as cellular hepatitis delta virus attachment receptors.
title_short Proteoglycans act as cellular hepatitis delta virus attachment receptors.
title_sort proteoglycans act as cellular hepatitis delta virus attachment receptors
url http://europepmc.org/articles/PMC3591349?pdf=render
work_keys_str_mv AT oscarlamaslongarela proteoglycansactascellularhepatitisdeltavirusattachmentreceptors
AT tobiastschmidt proteoglycansactascellularhepatitisdeltavirusattachmentreceptors
AT katrinschoneweis proteoglycansactascellularhepatitisdeltavirusattachmentreceptors
AT raffaellaromeo proteoglycansactascellularhepatitisdeltavirusattachmentreceptors
AT heinerwedemeyer proteoglycansactascellularhepatitisdeltavirusattachmentreceptors
AT stephanurban proteoglycansactascellularhepatitisdeltavirusattachmentreceptors
AT andreasschulze proteoglycansactascellularhepatitisdeltavirusattachmentreceptors